These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15907917)

  • 21. Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.
    He XC; Feng S; Wang ZF; Shi Y; Zheng S; Xia Y; Jiang H; Tang XC; Bai D
    Bioorg Med Chem; 2007 Feb; 15(3):1394-408. PubMed ID: 17126020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphoregulation by acetylcholinesterase in fibroblasts and astrocytes.
    Anderson AA; Ushakov DS; Ferenczi MA; Mori R; Martin P; Saffell JL
    J Cell Physiol; 2008 Apr; 215(1):82-100. PubMed ID: 17948252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge.
    Rydberg EH; Brumshtein B; Greenblatt HM; Wong DM; Shaya D; Williams LD; Carlier PR; Pang YP; Silman I; Sussman JL
    J Med Chem; 2006 Sep; 49(18):5491-500. PubMed ID: 16942022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrocyclic derivatives of 6-methyluracil: New ligands of the peripheral anionic site of acetylcholinesterase.
    Petrov K
    Int J Risk Saf Med; 2015; 27 Suppl 1():S72-3. PubMed ID: 26639720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors.
    Sheng R; Lin X; Li J; Jiang Y; Shang Z; Hu Y
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3834-7. PubMed ID: 15993600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New multipotent tetracyclic tacrines with neuroprotective activity.
    Marco-Contelles J; León R; de los Ríos C; García AG; López MG; Villarroya M
    Bioorg Med Chem; 2006 Dec; 14(24):8176-85. PubMed ID: 17005406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine.
    Rizzo S; Cavalli A; Ceccarini L; Bartolini M; Belluti F; Bisi A; Andrisano V; Recanatini M; Rampa A
    ChemMedChem; 2009 Apr; 4(4):670-9. PubMed ID: 19222043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
    Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synthesis and AchE inhibitory activity of 2-phenoxy-indan-1-one derivatives].
    Sheng R; Lin X; Li JY; Hu YZ
    Yao Xue Xue Bao; 2006 Feb; 41(2):115-20. PubMed ID: 16671539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholinesterase: how is structure related to function?
    Silman I; Sussman JL
    Chem Biol Interact; 2008 Sep; 175(1-3):3-10. PubMed ID: 18586019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholinesterase: A Primary Target for Drugs and Insecticides.
    Thapa S; Lv M; Xu H
    Mini Rev Med Chem; 2017; 17(17):1665-1676. PubMed ID: 28117022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.
    Bohn P; Le Fur N; Hagues G; Costentin J; Torquet N; Papamicaël C; Marsais F; Levacher V
    Org Biomol Chem; 2009 Jun; 7(12):2612-8. PubMed ID: 19503937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
    Akula N; Lecanu L; Greeson J; Papadopoulos V
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
    Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S
    Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
    Piazzi L; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
    Bioorg Med Chem; 2007 Jan; 15(1):575-85. PubMed ID: 17008100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active and peripheral anionic sites of acetylcholinesterase have differential modulation effects on cell proliferation, adhesion and neuritogenesis in the NG108-15 cell line.
    Campanha HM; Carvalho F; Schlosser PM
    Toxicol Lett; 2014 Oct; 230(2):122-31. PubMed ID: 24680925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
    Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
    Butini S; Campiani G; Borriello M; Gemma S; Panico A; Persico M; Catalanotti B; Ros S; Brindisi M; Agnusdei M; Fiorini I; Nacci V; Novellino E; Belinskaya T; Saxena A; Fattorusso C
    J Med Chem; 2008 Jun; 51(11):3154-70. PubMed ID: 18479118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
    Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
    J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.